“…More importantly, several studies have found that information conveyed by FD is additional to that provided by other conventional structural measures (Free et al, 1996 ; King et al, 2009 ; King et al, 2010 ; Lu, 2020 ; Madan & Kensinger, 2016 ; Madan & Kensinger, 2018 ). FD can detect changes in the structural complexity of the cerebral cortex in healthy ageing (Krohn et al, 2019 ; Liu et al, 2020 ; Madan & Kensinger, 2016 ; Marzi et al, 2020 ; Sandu, Staff, et al, 2014 ), neurological disorders (King et al, 2016 ; Ruiz de Miras et al, 2017 ; Sandu, Martinot, et al, 2014 ; Sheelakumari et al, 2018 ) and neuropsychological disorders (Narr et al, 2004 ; Nenadic et al, 2014 ; Nickel et al, 2019 ; Sandu, Rasmussen Jr., et al, 2008 ; Sandu, Specht, et al, 2008 ). Normal brain morphological alterations associated with ageing do not occur homogeneously and are region‐specific, thus region‐specific FD analysis might serve as a biomarker to track therapeutic interventions targeted at disorders associated with accelerated atrophy such as dementia and disease progression such as spinocerebellar ataxia (Marzi et al, 2018 ).…”